亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

AB1445 THE UNITED ARAB EMIRATES JUVENILE IDIOPATHIC ARTHRITIS REGISTRY PRELIMINARY RESULTS OF PATIENT DEMOGRAPHICS, SUBTYPE DISTRIBUTION, CLINICAL FEATURES, TREATMENT AND OUTCOME.

医学 关节炎 人口 内科学 儿科 家族史 回顾性队列研究 少年 物理疗法 环境卫生 遗传学 生物
作者
Khulood Khawaja,Mohammed Suhail Yasin Masalawala,Abid Naeem,Elham Sharif,Imrana Afrooz,Najla Aljaberi
标识
DOI:10.1136/annrheumdis-2023-eular.3528
摘要

Background

Juvenile Idiopathic Arthritis (JIA) is a chronic inflammatory disease that affects 1 in 1000 children worldwide. Our population in the United Arab Emirates is a multiethnic diverse population. [1, 2]

Objectives

To create centralised data for JIA in the United Arab Emirates. In this abstract we describe the Demographic data, clinical features, subtype distribution as per ILAR classification, treatment received and outcome of our patients.[3]

Methods

Retrospective entry of data from all 3 participating centres (Shaikh Shakhbout Medical City, Tawam and AlJalila). Patients with the diagnosis of JIA included. Electronic clinical research form used to collect data. Data at initial diagnosis and current outcome as per Wallace and (Juvenile Arthritis Disease Activity Score) JADAS 10. Long term out come as per Juvenile Arthritis Disease Activity (JADAI) articular > 0 and extra articular JADAI > 0. All data entered and analysed through Redcap (Research Electronic Data Capture web-based application version 12.1.1 model 2022). Simple statistics used. Ethics approval obtained.

Results

157 patients entered in to the registry so far. Male to female distribution: 39 (24.8%) to 118 (75.2%). Local Emirati patients of 107 (68.2%). Other Arabs 16 (10.2%). South Asian 12 (7.6%), Western 12 (7.6%) and African 10 6.4%). Mean age at presentation 5.3 years (1 to 15 years). Current mean age 12 (4-22 years). Family history of Rheumatoid Arthritis in 33 patients (21%). History of Consanguinity in 54 families (34.4%). Subtype distribution: Oligo articular 77 (49.4%), extended Oligo articular 5 (3.2%). Poly articular 50 (32.1%), Systemic 11 (7.1%), Enthesitis related Arthritis 1 (0.6%), Psoriatic 9 (5.8%) and other 3 (1.9%). At presentation: Joint pain in 132 patients (84.1%), Joint effusion 115 (73.2%). Affected function in 98 (63.2%). Clinical synovitis in 138 (87.9%). Joint restriction in 100 (63.7%). Uveitis in 6 (3.8%) ANA positive 35 patients (22.3%). Rheumatoid factor positive 10 (6.4%), Anti CCP positive 6 (3.8%). Low Hb less than 10 g/L in 109 (69.4%), high ESR > 20 mm/hr in 30 patients (19.1%). High CRP >5 mg/L in 48 (30.6%). Synovitis in USS 53 (33.8%). Erosions by X-ray or USS 7 patients (4.5%). Uveitis after diagnosis in 30 patients 19.1%. Dental carries at presentation in 51 patients (32.1%). COVID infection in 74 patients (47.1%). Oral systemic steroids given to 108 patients (68.8%). Intravenous methyl prednisolone to 43 patients 27.4%). Triamcinolone Acetonide/Hexa acetonide joint injections to 91 patients (58%). Synthetic Disease modifying medication methotrexate in 108 (68.8%). Biologic treatment 76 patients (49%). Etanercept 64 patients (40.8%), Adalimumab 65 patients (41.4%), Tocilizumab intra venous 32 (20.4%) and sub cut in 10 patients (6.4%). Canakinumab 9 patients (5.7%), Anakinra 8 patients (5.1%) and Infliximab in 10 patients (6.4%). Oral Tofacitinib in 2 patients (1.3%). In regards to outcome as per Wallace criteria and JADAS 10; active disease in 16 patients (10.2%). In remission 141 patients (89.8%). Out of these in remission on treatment 118 (83.7%) and in remission off treatment 23 patients (16.3%). JADAI articular >0 in 8 patients (5%) and JADAI extra articular >0 in 14 patients (8.9%)

Conclusion

We have diverse cohort and high percentage of consanguinity in our families of children with JIA (34.4%). Biologic treatment required in 49% of patients. Patients In remission 89.8%. Out of this 83.77% in remission on treatment and 8.9% in remission off treatment. Further studies needed to understand our population better with focus of effect of consanguinity.

References

[1] Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007 Mar 3;369(9563):767-778 [2] UAE National Bureau of Statistics. www.scad.ae. Accessed 12th of January 2023 [3] Petty RE et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004 Feb; 31(2):390-2.

Acknowledgements

We are grateful to all the children and families for allowing us to use their data.

Disclosure of Interests

None Declared.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
NexusExplorer的应助被Uu采纳,获得10
6秒前
jiujiu发布了新的文献求助10
8秒前
11秒前
yf完成签到,获得积分10
17秒前
h11的应助被mmyhn采纳,获得10
17秒前
小蘑菇的应助被jiujiu采纳,获得10
21秒前
甜蜜的夕阳完成签到,获得积分10
36秒前
37秒前
null的应助被科研通管家采纳,获得10
37秒前
null的应助被科研通管家采纳,获得10
37秒前
null的应助被科研通管家采纳,获得10
37秒前
直率的晓亦完成签到,获得积分10
42秒前
null的应助被Ella采纳,获得10
44秒前
樵木完成签到,获得积分10
44秒前
自信紫夏的应助被mmyhn采纳,获得10
48秒前
48秒前
复杂芷文完成签到,获得积分10
1分钟前
jerry完成签到,获得积分10
1分钟前
1分钟前
简单的语风完成签到,获得积分10
1分钟前
1分钟前
Terry发布了新的文献求助10
1分钟前
1分钟前
Richard发布了新的文献求助10
1分钟前
1分钟前
Terry完成签到,获得积分20
1分钟前
Ella发布了新的文献求助10
1分钟前
1分钟前
务实的海豚完成签到,获得积分10
1分钟前
Ella发布了新的文献求助10
2分钟前
2分钟前
无极微光的应助被祟祟采纳,获得20
2分钟前
2分钟前
动听的天宇完成签到,获得积分10
2分钟前
内向鸣凤完成签到,获得积分10
2分钟前
fpy完成签到,获得积分10
2分钟前
null的应助被科研通管家采纳,获得10
2分钟前
2分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158746
求助须知:如何正确求助?哪些是违规求助? 9554476
关于积分的说明 21719232
捐赠科研通 7748291
什么是DOI,文献DOI怎么找? 3427072
关于科研通互助平台的介绍 2551971
邀请新用户注册赠送积分活动 2471332